Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login

Breast cancer

Calcium channel blockers not linked to breast cancer risk

Analysis of data on 50,757 women conflicts with previous research that suggested calcium channel blockers increase breast cancer risk

A study published in 2013 showed that women taking calcium channel blockers for at least ten years had a two-fold increased risk of breast cancer[1].

To explore this association prospectively, US researchers analysed data on 50,757 women from a study that has followed the sisters of women with breast cancer since 2003. 

Over a median follow-up of 5.3 years, the risk of developing breast cancer was the same for long-term users of calcium channel blockers and women who did not take them. The rate of long-term calcium channel blocker use was identical (1.3%) among women who did and did not develop cancer. 

Reporting in Breast Cancer Research (online, 5 July 2016)[2], the team says their findings do not support previous reports suggesting an increased breast cancer risk, concerns over which could lead women to receive less effective hypertension treatment.

Citation: The Pharmaceutical Journal DOI: 10.1211/CP.2016.20201470

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Supplementary images

  • Woman taking tablet

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.